CINECA IRIS Institutional Research Information System

FOGLI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.243
AS - Asia 4.904
EU - Europa 4.698
SA - Sud America 675
AF - Africa 241
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 3
Totale 20.800
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.917
SG - Singapore 1.657
IT - Italia 1.483
CN - Cina 1.351
DE - Germania 727
HK - Hong Kong 675
SE - Svezia 647
BR - Brasile 557
VN - Vietnam 383
GB - Regno Unito 366
BG - Bulgaria 287
CA - Canada 228
FR - Francia 226
TR - Turchia 198
FI - Finlandia 183
IN - India 176
RU - Federazione Russa 165
AT - Austria 133
JP - Giappone 113
CI - Costa d'Avorio 82
PL - Polonia 81
UA - Ucraina 78
MX - Messico 57
BD - Bangladesh 53
KR - Corea 51
CH - Svizzera 49
GR - Grecia 49
NL - Olanda 48
ES - Italia 43
AR - Argentina 39
BE - Belgio 39
SN - Senegal 37
AU - Australia 33
PK - Pakistan 30
ZA - Sudafrica 30
IQ - Iraq 28
IL - Israele 26
MA - Marocco 24
ID - Indonesia 23
IR - Iran 22
NG - Nigeria 20
RO - Romania 20
SA - Arabia Saudita 19
CO - Colombia 18
VE - Venezuela 18
EC - Ecuador 16
PT - Portogallo 12
EG - Egitto 11
RS - Serbia 11
PH - Filippine 10
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 9
JO - Giordania 9
KE - Kenya 9
TW - Taiwan 9
MY - Malesia 8
NP - Nepal 8
UY - Uruguay 8
AL - Albania 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
HU - Ungheria 6
JM - Giamaica 6
LT - Lituania 6
PE - Perù 6
AZ - Azerbaigian 5
CL - Cile 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
LB - Libano 5
PY - Paraguay 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
BY - Bielorussia 4
IE - Irlanda 4
PA - Panama 4
SV - El Salvador 4
AO - Angola 3
BJ - Benin 3
BO - Bolivia 3
CY - Cipro 3
DK - Danimarca 3
DM - Dominica 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NO - Norvegia 3
PS - Palestinian Territory 3
SI - Slovenia 3
TH - Thailandia 3
A1 - Anonimo 2
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
DZ - Algeria 2
GD - Grenada 2
GH - Ghana 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
OM - Oman 2
BA - Bosnia-Erzegovina 1
Totale 20.774
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.048
Ashburn 1.033
Singapore 850
Fairfield 702
Hong Kong 659
Santa Clara 635
Chandler 605
Ann Arbor 604
Houston 564
Dallas 516
San Jose 452
Serra 307
Shanghai 300
Sofia 284
Seattle 279
Beijing 266
Wilmington 265
New York 218
Milan 215
Cambridge 214
Los Angeles 166
Boardman 159
Ottawa 157
Princeton 144
Pisa 128
Lawrence 119
Vienna 118
London 107
Izmir 105
Medford 105
Lauterbourg 101
Ho Chi Minh City 97
Jacksonville 94
Tokyo 94
Florence 90
Nanjing 86
Munich 84
Abidjan 82
Hefei 81
Frankfurt am Main 78
Rome 72
Council Bluffs 71
Warsaw 68
Dearborn 67
Hanoi 65
Des Moines 61
São Paulo 56
Dong Ket 54
Redwood City 54
Redondo Beach 53
Helsinki 49
Buffalo 48
Istanbul 47
Ogden 45
Seoul 44
Lancaster 40
Dakar 37
Turku 36
Marseille 35
Nanchang 34
San Diego 34
Bern 33
Columbus 30
The Dalles 29
Brussels 27
Jüchen 25
Phoenix 25
Falls Church 24
Pune 24
Chennai 23
Toronto 23
Bremen 22
Kunming 22
Orem 22
Tianjin 22
Fuzhou 21
Changsha 20
Chicago 20
Guangzhou 20
Lagos 20
Nürnberg 20
San Francisco 20
Montreal 19
Belo Horizonte 18
Rio de Janeiro 18
Brooklyn 17
Mumbai 17
Brasília 15
Cascina 15
Johannesburg 15
Norwalk 15
Shenyang 15
Lucca 14
Naples 14
Pistoia 14
Stockholm 14
Wuhan 14
Zurich 14
Amsterdam 13
Hebei 13
Totale 14.047
Salva come PNG Salva come JPEG
Nome #
Cytotoxic Activity of Oleocanthal Isolated from Virgin Olive Oil on Human Melanoma Cells 369
The molecular bases of cannabinoid action in cancer 341
AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells 323
Synthesis of Novel 3,5-Disubstituted-2-oxindole Derivatives As Antitumor Agents against Human Nonsmall Cell Lung Cancer 289
Anticancer activity of euplotin C, isolated from the marine ciliate euplotes crassus, against human melanoma cells 282
Circulating MicroRNAs in Cutaneous Melanoma Diagnosis and Prognosis 258
Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer 254
Cholinesterase-like organocatalysis by imidazole and imidazole-bearing molecules 245
Sucrosomial iron and traditional iron dosage forms are compared for absorption by Caco2 cells. 239
Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism 236
A flexible SNP genotyping system to study allelic determinants of brain function. 233
Variable correlation between 6-mercaptopurine metabolites in erythrocytes and hematologic toxicity: implications for drug monitoring in children with acute lymphoblastic leukemia 233
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity 228
Survivin-directed molecular beacon as potential theranostic agent in melanoma cells 224
Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle. 222
Anti-proliferative activity of oleocanthal in human malignant cutaneous melanoma cells 221
Analysis of the Antitumor Activity of Clotrimazole on A375 Human Melanoma Cells 221
Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer 214
Selection of a human butyrylcholinesterase-like antibody single-chain variable fragment resistant to AChE inhibitors from a phage library expressed in E. coli. 213
Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma 208
Rosiglitazone reverses salbutamol-induced ß(2) -adrenoceptor tolerance in airway smooth muscle. 207
Survivin mRNA detection and silencing by a Molecular Beacon Oligodeoxynucleotide in living cutaneous melanoma cells 202
Detection and silencing of survivin mRNA by bi-color imaging based on PMMA nanoparticles/molecular beacon in human cancer cells 201
Anticancer activity of anandamide in human cutaneous melanoma cells 199
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients 197
Role of miR-34a as biomarker and therapeutic agent in cutaneous melanoma 195
Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma. 193
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer 193
Chronic administration of suramin induces neurotoxicity in rats 192
Lung tissue penetration and plasma pharmacokinetics of azithromycin after multiple oral doses of 500 and 1000 mg in adults 191
Survivin directed molecular beacon as potential “theranostic agent” in melanoma cells 191
Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells. 188
An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma. 184
Synergistic interaction between PPAR ligands and salbutamol on human bronchial smooth muscle cell proliferation. 181
Cytotoxic effects of Echinacea root hexanic extracts on human cancer cell lines 180
Evaluation of circulating microRNAs as diagnostic circulating biomarkers in cutaneous melanoma 180
Identification of five circulating microRNAs with high diagnostic values in cutaneous melanoma 179
Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells 179
Cannabinoid derivatives induce cell death in MIA Paca-2 cell line via a receptor-indipendent mechanism 177
Diagnosis and treatment monitoring in breast cancer: how liquid biopsy can support patient management 177
Clinical pharmacology of intravitreal anti-VEGF drugs 176
Potential relationship between the expression of Cx26/Cx43 and the BRAF mutation status in human melanoma cells 175
Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy 175
Montelukast prevents microparticle-induced inflammatory and functional alterations in human bronchial smooth muscle cells. 175
Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting 175
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression 173
Antiproliferative effects of Echinacea root hexanic extracts on Mia Paca-2 cells 173
Matrix metalloproteinase inhibitors prevent the release and proteolytic activity of monocyte/macrophage-derived microparticles 173
Genotype-based therapeutic approach for colorectal cancer: state of the art and future perspectives 172
Theranostic properties of a survivin-directed molecular beacon in human melanoma cells 172
Pharmacogenetic determinants of anti-cancer drug activity and toxicity 168
Implications of KRAS mutations in acquired resistance to treatment in NSCLC 167
Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma 165
Montelukast reverses albuterol-induced b2-adrenoceptor tolerance in airway smooth muscle 163
A flexible SNP genotyping system to study allelic determinants of brain function 161
Ceramide analogues in apoptosis: a new strategy for anticancer drug development 160
Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer 157
Therapeutic potential of sulindac hydroxamic acid against human pancreatic and colonic cancer cells 157
Pathophysiology and pharmacological targets of VEGF in diabetic macular edema 157
Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer 156
Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo 156
Gemcitabine plus nab-paclitaxel induces PD-L1 mRNA expression in plasma-derived microvesicles in pancreatic cancer 156
Design, synthesis and pro-apoptotic antitumour properties of indole-based 3,5-disubstituted oxadiazoles 155
Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs 153
Sucrosomial® iron absorption studied by in vitro and ex-vivo models 153
Pharmacogenetic foundations of therapeutic efficacy and adverse events of statins 152
In vitro investigation of sulindac derivatives as potential anticancer agents 151
Synthesis and evaluation of indole-containing 3,5-diarylisoxazoles as potential pro-apoptotic antitumour agents. 151
Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naïve patients with advanced non-small-cell lung cancer 151
Conformationally restrained ceramide analogues: effects of lipophilic modifications on the antiproliferative activity 149
Synthesis, characterization and evaluation of thiolated quaternary ammonium-chitosan conjugates for enhanced intestinal drug permeation 148
Design, synthesis, and characterization of the antitumor activity of novel ceramide analogues 148
EGFR-TKIs in non-small-cell lung cancer: Focus on clinical pharmacology and mechanisms of resistance 148
High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study 145
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy 145
In vivo adenosine A(2B) receptor desensitization in guinea-pig airway smooth muscle: Implications for asthma 143
Manumycin inhibits ras signal transduction pathway and induces apoptosis in COLO320-DM human colon tumour cells 136
Influence of polysaccharides on expression of membrane-associated muc1 in cultivated epithelial cells 135
Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients 135
Synthesis, characterization and evaluation of thiolated quaternary ammonium-chitosan conjugates for enhanced intestinal drug permeation 135
The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide 135
Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer 135
Attività antiproliferativa dell’oleocantale in cellule umane di melanoma cutaneo maligno. 133
Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors 132
Farmacogenetica nelle neoplasie gastriche 131
Metabolism of 6-mercaptopurine in the erythrocytes, liver, and kidney of rats during multiple-dose regimens 129
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review 127
New chitosan derivatives for the preparation of rokitamycin loaded microspheres designed for ocular or nasal administration 127
Pharmacological insights on novel oral selective estrogen receptor degraders in breast cancer 125
The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage 125
Erratum: Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers 125
Nicotine Metabolite Ratio in Smokers: A Real World Experience 125
Drug-drug interactions in breast cancer patients treated with CDK4/6 inhibitors 124
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study 123
ErbB in NSCLC as a molecular target: Current evidences and future directions 121
Cross-Linked Hyaluronic Acid as Tear Film Substitute 120
Characteristics of smokers according to their Nicotine Metabolite Ratio, preliminary results from a real-life experience 120
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib 120
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers 119
Relazione tra profilo metabolico della nicotina e caratteristiche demografiche, cliniche e di abitudine al fumo. Risultati preliminari nella vita reale 116
Totale 17.646
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.329
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.329
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021221 0 0 0 0 0 0 0 0 0 0 78 143
2021/20221.479 43 77 65 90 233 212 60 70 63 49 86 431
2022/20232.062 257 292 162 169 194 278 37 152 371 10 126 14
2023/20241.411 142 163 158 83 176 252 71 52 29 51 107 127
2024/20254.463 49 173 47 245 506 530 294 200 479 525 456 959
2025/20264.675 342 514 550 465 586 393 787 227 283 405 123 0
Totale 21.206